Shanglun Yang
机构：Sichuan University, Meizhou City People's Hospital, West China Hospital of Sichuan University
发表论文 4 篇 · 总被引 37 次 · h-index 1
代表论文
- CRISPR/Cas9-based gene-editing technology for sickle cell disease (2023 · Gene · 被引 36)
- A Novel Conditioning Regimen Combining Selinexor with Melphalan Could Improve Survival of Patients with Multiple Myeloma (2024 · Blood · 被引 1)
- A novel conditioning regimen combining selinexor with melphalan Improves Survival in Patients with multiple myeloma:a prospective study (2025 · Blood)
- Sorafenib Combined with DOAP Regimen for the Treatment of BRAF V600E-Negative Langerhans Cell Sarcoma: A three-year follow-up result (2024)